A producing facility in Wisconsin, USA, has been bought by Eli Lilly (NYSE: LLY) with a purpose to help rising demand for its medicines. Nexus Prescribed drugs, a sterile producer supplying the pharmaceutical {industry}, has agreed to promote the US Meals and Drug Administration-approved facility for an undisclosed sum. The positioning might be used to…
